IQV · News · 20260808N

Acquisition / Partnership / Divestiture

IQVIA HOLDINGS INC. · 2026-08-08 · Importance 31 · Surprise 42

IQVIA announced a strategic collaboration with Medera Inc. to advance cardiac gene therapies and human-based drug discovery. IQVIA will contribute clinical-trial infrastructure, while Medera will contribute its gene-therapy platform and cardiovascular drug-development capabilities. The collaboration expands IQVIA’s involvement in gene therapy and innovative drug development without a disclosed transaction value. The partnership is intended to accelerate cardiac gene-therapy development and human-based discovery programs.

Key facts

• Assenagon Asset Management S.A. increased its IQVIA stake by 47.3% in the second quarter by purchasing an additional 109,284 shares. source
• Community Trust & Investment Co. increased its stake in IQVIA by 5% in the second quarter to 92,668 shares valued at $17.9 million. source